← BioTransfer GEO Dataset Finder
GEO series

Therapy-induced Secretion of Spliceosomal Components Mediates Pro-Survival Crosstalk Between Ovarian Cancer Cells

GSE241914 Homo sapiens (human) RNA-seq (gene expression) 60 samples Submitted 2024/04/24 Platform GPL18573Platform GPL16791
At a glance

RNA-seq (gene expression) · human · 60 samples

What it is
RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
Organism
Homo sapiens (human)
Topic
Ovarian cancerThis series is part of our curated briefing on it.
Samples
60 samples: 16 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
Data you can get
A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Paper
Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cellsNature communications · 2024
SuperSeries — this record groups several sub-series.
Summary (written by the submitters)
This SuperSeries is composed of the SubSeries listed below.
Published in
Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells
Shender VO, Anufrieva KS, Shnaider PV et al. · Nature communications 2024 · PMID 38898005 · doi:10.1038/s41467-024-49512-6
This dataset
Open GSE241914 in finder → Find more human RNA-seq datasets → Ovarian cancer landscape →
Download · which file do I need?

Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.

1 · Just have a look

Processed table

The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.

Series matrix ↓
2 · Re-analyse it

Supplementary files

The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE241914_RAW.tar (it can run to tens of gigabytes).

All supplementary files ↗ Whole study · RAW.tar ↓
3 · Start from the raw reads

Raw sequencing reads

The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.

Raw reads on ENA ↗

What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.

Also filed as BioProject PRJNA1010733 and SRA study SRP457516. Searching any of these in the dataset finder brings you back here.

NCBI GEO page ↗ Paper (PMID 38898005) ↗
Study design
16 conditions, mostly in triplicate
cancer cells from patient 1 incubated with as… ×3 cancer cells from patient 1 incubated with as… ×3 SKOV3 + control secretome, repeat ×3 SKOV3 + therapy-induced secretome, repeat ×3 SKOV3 control, repeat ×3 SKOV3 transfected U12 snRNA, repeat ×3 SKOV3 transfected U6atac snRNA, repeat ×3 SKOV3 transfected control fragment of mRNA GF… ×3 +28 more

Supports a case/control comparison: 31 samples read as cases, 11 as controls.

How we read this: 16 replicated groups read from 60 sample titles; they account for 40 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.

Samples in this study

+ 20 more — browse all 60 samples with per-sample file links →

More Ovarian cancer datasets

Search all human RNA-seq datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.